Overview

Screening Contrast-Enhanced Mammography as an Alternative to MRI

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
There are women for whom a screening breast MRI is clinically recommended, but not feasible either due to patient factors (body habitus, pacemaker or other implant, claustrophobia) or access (cost, other constraints). Contrast-enhanced mammography (CEM) is a potential alternative to MRI for screening that uses updated standard mammography equipment to obtain low- and high-energy images after intravenous injection of iodinated contrast (as used in CT scanning). The investigators seek to validate screening CEM as an alternative to screening MRI.
Phase:
Phase 4
Details
Lead Sponsor:
Wendie Berg
Collaborator:
PA Breast Cancer Coalition